Literature DB >> 21799000

IGF-I stimulates cooperative interaction between the IGF-I receptor and CSK homologous kinase that regulates SHPS-1 phosphorylation in vascular smooth muscle cells.

Yashwanth Radhakrishnan1, Xinchun Shen, Laura A Maile, Gang Xi, David R Clemmons.   

Abstract

IGF-I plays an important role in smooth muscle cell proliferation and migration. In vascular smooth muscle cells cultured in 25 mm glucose, IGF-I stimulated a significant increase in Src homology 2 domain containing protein tyrosine phosphatase substrate-1 (SHPS-1) phosphorylation compared with 5 mm glucose and this increase was required for smooth muscle cell proliferation. A proteome-wide screen revealed that carboxyl-terminal SRC kinase homologous kinase (CTK) bound directly to phosphotyrosines in the SHPS-1 cytoplasmic domain. Because the kinase(s) that phosphorylates these tyrosines in response to IGF-I is unknown, we determined the roles of IGF-I receptor (IGF-IR) and CTK in mediating SHPS-1 phosphorylation. After IGF-I stimulation, CTK was recruited to IGF-IR and subsequently to phospho-SHPS-1. Expression of an IGF-IR mutant that eliminated CTK binding reduced CTK transfer to SHPS-1, SHPS-1 phosphorylation, and cell proliferation. IGF-IR phosphorylated SHPS-1, which provided a binding site for CTK. CTK recruitment to SHPS-1 resulted in a further enhancement of SHPS-1 phosphorylation. CTK knockdown also impaired IGF-I-stimulated SHPS-1 phosphorylation and downstream signaling. Analysis of specific tyrosines showed that mutation of tyrosines 428/452 in SHPS-1 to phenylalanine reduced SHPS-1 phosphorylation but allowed CTK binding. In contrast, the mutation of tyrosines 469/495 inhibited IGF-IR-mediated the phosphorylation of SHPS-1 and CTK binding, suggesting that IGF-IR phosphorylated Y469/495, allowing CTK binding, and that CTK subsequently phosphorylated Y428/452. Based on the above findings, we conclude that after IGF-I stimulation, CTK is recruited to IGF-IR and its recruitment facilitates CTK's subsequent association with phospho-SHPS-1. This results in the enhanced CTK transfer to SHPS-1, and the two kinases then fully phosphorylate SHPS-1, which is necessary for IGF-I stimulated cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21799000      PMCID: PMC3165910          DOI: 10.1210/me.2011-0035

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  43 in total

1.  Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts.

Authors:  Deirdre A Buckley; Alan Cheng; Patrick A Kiely; Michel L Tremblay; Rosemary O'Connor
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.

Authors:  Yashwanth Radhakrishnan; Walker H Busby; Xinchun Shen; Laura A Maile; David R Clemmons
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

3.  Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells.

Authors:  Radoslaw Zagozdzon; Cécile Bougeret; Yigong Fu; Hava Karsenty Avraham
Journal:  Int J Oncol       Date:  2002-12       Impact factor: 5.650

4.  Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor.

Authors:  N Elbaz; K Bedecs; M Masson; M Sutren; A D Strosberg; C Nahmias
Journal:  Mol Endocrinol       Date:  2000-06

5.  Regulation of insulin-like growth factor I receptor dephosphorylation by SHPS-1 and the tyrosine phosphatase SHP-2.

Authors:  Laura A Maile; David R Clemmons
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

6.  The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.

Authors:  Laura A Maile; Jane Badley-Clarke; David R Clemmons
Journal:  Mol Biol Cell       Date:  2003-05-29       Impact factor: 4.138

7.  Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer.

Authors:  Soyoun Kim; Radoslaw Zagozdzon; Alan Meisler; James D Baleja; Yigong Fu; Shalom Avraham; Hava Avraham
Journal:  J Biol Chem       Date:  2002-07-16       Impact factor: 5.157

8.  Conserved hydrophobicity in the SH2-kinase linker is required for catalytic activity of Csk and CHK.

Authors:  Esa T Mikkola; Mathias Bergman
Journal:  FEBS Lett       Date:  2003-06-05       Impact factor: 4.124

9.  Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.

Authors:  S I Chisalita; G S Johansson; E Liefvendahl; K Bäck; H J Arnqvist
Journal:  J Mol Endocrinol       Date:  2009-07-09       Impact factor: 5.098

10.  A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity.

Authors:  Yuh-Ping Chong; Terrence D Mulhern; Hong-Jian Zhu; Donald J Fujita; Jeffrey D Bjorge; John-Paul Tantiongco; Nikolaos Sotirellis; Daisy Sio Seng Lio; Glen Scholz; Heung-Chin Cheng
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

View more
  11 in total

1.  Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization.

Authors:  Gang Xi; Xinchun Shen; Christine Wai; Morris F White; David R Clemmons
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

Review 2.  IGF-1 and cardiovascular disease.

Authors:  Yusuke Higashi; Sandeep Gautam; Patrick Delafontaine; Sergiy Sukhanov
Journal:  Growth Horm IGF Res       Date:  2019-01-31       Impact factor: 2.372

3.  The coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase β (RPTPβ).

Authors:  Xinchun Shen; Gang Xi; Christine Wai; David R Clemmons
Journal:  J Biol Chem       Date:  2015-03-18       Impact factor: 5.157

4.  Down-regulation of Insulin Receptor Substrate 1 during Hyperglycemia Induces Vascular Smooth Muscle Cell Dedifferentiation.

Authors:  Gang Xi; Christine Wai; Morris F White; David R Clemmons
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

5.  Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigs.

Authors:  Laura A Maile; Walker H Busby; Katherine A Gollahon; William Flowers; Nikol Garbacik; Stefani Garbacik; Kara Stewart; Timothy Nichols; Dwight Bellinger; Amit Patel; Paul Dunbar; Matt Medlin; David Clemmons
Journal:  Endocrinology       Date:  2014-08-29       Impact factor: 4.736

6.  Hyperglycemia stimulates p62/PKCζ interaction, which mediates NF-κB activation, increased Nox4 expression, and inflammatory cytokine activation in vascular smooth muscle.

Authors:  Gang Xi; Xinchun Shen; Christine Wai; Caroline K Vilas; David R Clemmons
Journal:  FASEB J       Date:  2015-07-31       Impact factor: 5.191

7.  Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.

Authors:  Xinchun Shen; Gang Xi; Laura A Maile; Christine Wai; Clifford J Rosen; David R Clemmons
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

8.  Trastuzumab-induced recruitment of Csk-homologous kinase (CHK) to ErbB2 receptor is associated with ErbB2-Y1248 phosphorylation and ErbB2 degradation to mediate cell growth inhibition.

Authors:  Milos Dokmanovic; Yun Wu; Yi Shen; Jieqing Chen; Dianne S Hirsch; Wen Jin Wu
Journal:  Cancer Biol Ther       Date:  2014-05-16       Impact factor: 4.742

9.  Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.

Authors:  Gahana Advani; Ya Chee Lim; Bruno Catimel; Daisy Sio Seng Lio; Nadia L Y Ng; Anderly C Chüeh; Mai Tran; Mohd Ishtiaq Anasir; Heather Verkade; Hong-Jian Zhu; Benjamin E Turk; Thomas E Smithgall; Ching-Seng Ang; Michael Griffin; Heung-Chin Cheng
Journal:  Cell Commun Signal       Date:  2017-08-07       Impact factor: 5.712

Review 10.  Acromegaly, inflammation and cardiovascular disease: a review.

Authors:  Thalijn L C Wolters; Mihai G Netea; Niels P Riksen; Adrianus R M M Hermus; Romana T Netea-Maier
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.